Insights into Company Bills & Payments

Vijay Solvex Limited

📍 Alwar, Rajasthan, India Active NSE VIJSOLX CIN L15142RJ1987PLC004232
Search companies

Key Metrics of Vijay Solvex Limited

Revenue₹1,831 Cr▲ 0.1% YoYFY 2024-25
EBITDA₹26.7 Cr▲ 515.7% YoY
Net profit₹18.4 Cr▲ 681.7% YoY
Net worth—
Competitors10identified

About Vijay Solvex Limited

Sectors

Food & BeveragesPackaged Foods & Confectionery

Company details

Registered office
Bhagwati Sadan Swami Dayanand Marg Station Road,, Alwar, In-rj, 301001
Listed
NSE: VIJSOLX · ₹729.70

Operational Areas of Vijay Solvex Limited

Company summary

Entity details

CINL15142RJ1987PLC004232
LEI code335800R9DEMKBVDESS18
State codeRJ
PIN code301001
Current legal nameVIJAY SOLVEX LIMITED
Classification—
Listing statusListed
Registration no.004232
Company age—
PAN—
CountryIndia
CityAlwar
StateRajasthan
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code15142
Description of main activityManufacture of food products and beverages
Description of business activityManufacture of food products and beverages
SectorOther Industries · Discovered Companies

Share price · NSE: VIJSOLX

VIJSOLX on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 23 Oct 2025 Withdrawn Stable outlook · Short term A4 · Withdrawn
Change in last 12 monthsNo change
Change since first rating on record▼ 3 notchessince Mar 2018
Rating actions100 up · 1 down

WatchIssuer not cooperating with CARE (rating based on limited information)

NoteLatest action: rating withdrawn (CARE, 23 Oct 2025)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
23 Oct 2025CAREWithdrawn BBA4Stable— View
14 May 2025CAREDowngraded (from BB+) BBA4Stable₹170 Cr View
23 Feb 2024CARERevised (from BBB) BB+A3+Stable₹170 Cr View
06 Jan 2023CAREReaffirmed BBBA3+Stable₹170 Cr View
08 Feb 2022CAREReaffirmed BBBA3+Stable₹170 Cr View
06 Jan 2022CAREReaffirmed BBBA3+Stable₹240 Cr View
06 Jan 2021CARERevised (from BBB) BBBA3+Stable₹240 Cr View
31 Dec 2019CAREOther ———— View
04 Apr 2019CAREOther ———— View
14 Mar 2018CAREOther ———— View

Credit strengths (CARE, Oct 2025)

+ Comfortable capital structure albeit moderate debt coverage indicators

Despite increase in total debt mainly in form of working capital borrowing, the capital structure was comfortable as marked by an overall gearing ratio of 0.11x as on March 31, 2025 as against 0.03x as on March 31, 2024 owing to a healthy networth base. The company’s debt coverage indicators improved as a result of increased operating profitability in absolute termsand remained satisfactory as marked by interest coverage ratio of 7.67x during FY25 against 4.30x during FY24(Audited). Further,

+ Brief Financials (₹ crore) March 31, 2024 (A) March 31, 2025 (A) Q1FY26 (UA)

Total operating income 1829.23 1830.73 460.55 PBILDT 4.33 26.66 2.76 PAT 2.35 18.37 1.02 Overall gearing (times) 0.03 0.11 - Interest coverage (times) 4.30 7.67 - A: Audited UA: Unaudited; Note: ‘the above results are latest financial results available’ Status of non-cooperation with previous CRA: Not applicable

+ Total operating income 1829.23 1830.73 460.55

PBILDT 4.33 26.66 2.76 PAT 2.35 18.37 1.02 Overall gearing (times) 0.03 0.11 - Interest coverage (times) 4.30 7.67 - A: Audited UA: Unaudited; Note: ‘the above results are latest financial results available’ Status of non-cooperation with previous CRA: Not applicable Any other information: Not applicable

+ No. Type Outstanding Rating

Facilities assigned in assigned in assigned in assigned in (₹ crore) 2025-2026 2024-2025 2023-2024 2022-2023 1)CARE BB; Stable; ISSUER NOT COOPERATIN

+ LT: Long term; ST: Short term; LT/ST: Long term/Short term

Annexure-3: Detailed explanation of covenants of rated instruments/facilities: Not applicable Annexure-4: Complexity level of instruments rated Sr. No. Name of the Instrument Complexity Level 1 Fund-based - LT-Cash Credit Simple 2 Fund-based - LT/ ST-Cash Credit Simple 3 Fund-based - ST-Term loan Simple 4 Non-fund-based - ST-Letter of credit Simple

Credit challenges

− Moderate scale of operations with thin profitability in FY25 and Q1FY26

As per FY25 the scale of operation as marked by total operating income has been remained in stable on Y-o-Y basis at Rs.1830.73 Crores during FY25 as against Rs.1829.23 Crores during FY24 stable revenue generation from Edible oils and Ceramic segments. In Q1FY26, VSL has reported total income from operations worth Rs. 460.55crore. Profitability of VSL improved on back of lower cost of material albeit remained low owing to its low value-added nature of

− Pending litigations against the company

As articulated by the management, VSL is the registered owner of ‘Scooter’ trademark/device/logo and copyright holder for the artwork of SCOOTER Wavy device which is registered with Registrar of Trade Mark and Copyright and is defending its right before the Hon’ble Courts and Tribunals, wherever the challenges against use of ‘Scooter’ and /or any other intellectual property rights of the Company have been made. Further, during FY10, some shareholders had moved petition before National

− Key Strengths

Wide experience of promoters in edible oil industry and operational synergies with group entities: Being part of Nirajan Lal Data group (NLDG), top management of VSL has vast experience in edible oil industry. Mr Vijay Data, Managing Director, has more than three decades of experience in edible oil industry and looks after day to day operations of edible oil division. Mr. Daya Kishan Data, whole time director and Mechanical Engineer by qualification, has more than two

− Comfortable capital structure albeit moderate debt coverage indicators

Despite increase in total debt mainly in form of working capital borrowing, the capital structure was comfortable as marked by an overall gearing ratio of 0.11x as on March 31, 2025 as against 0.03x as on March 31, 2024 owing to a healthy networth base. The company’s debt coverage indicators improved as a result of increased operating profitability in absolute termsand remained satisfactory as marked by interest coverage ratio of 7.67x during FY25 against 4.30x during FY24(Audited). Further,

Could lead to an upgrade

• Substantial growth in scale of operations while sustaining PBILDT margin beyond 4.00% • Sustaining its capital structure with overall gearing going below 0.50 times

Could lead to a downgrade

Factors that could lead to negative rating action/downgrade • Decline in total operating income (TOI) by more than 30% from envisaged level and fall in PBILDT margin below 2.25% on sustained basis • Overall gearing deteriorating beyond 1.00 times on sustained basis • Any adverse outcome of pending litigations against company

Agency-reported financials (CARE, 23 Oct 2025)

MetricMarch 31, 2024March 31, 2025Q1FY26
Total operating income₹1,829 Cr₹1,831 Cr₹461 Cr
PBILDT₹4.33 Cr₹26.66 Cr₹2.76 Cr
PAT₹2.35 Cr₹18.37 Cr₹1.02 Cr
Overall gearing (times)0.03×0.11×—
Interest coverage (times)4.30×7.67×—
Revenue growth (YoY)—0.1%—
EBITDA margin0.2%1.5%0.6%
Implied interest cost (EBITDA ÷ coverage)₹1.01 Cr₹3.48 Cr—
PAT margin0.1%1.0%0.2%

Borrowings & rated debt

Rated borrowing limits (latest)₹170 Cr
Peak rated limits₹240 CrJan 2021 · CARE
Limits raised0 times1 new facility rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
continues to remain under ISSUER ISSUER Long Term Bank Facilities NOTWorking capital & bank lines—₹27.0 Cr— BB (Stable)Non-cooperatingCARE
NOT continues to remain under ISSUER Long Term Short Term Bank NOT A4+ continues to remain under ISSUERWorking capital & bank lines—₹60.0 Cr— BB / A4 (Stable)DowngradedCARE
Facilities CARE ISSUER NOT Short Term Bank Facilities NOTWorking capital & bank lines—₹83.0 Cr— A4DowngradedCARE

CARE ratings on record (checked 26 Oct 2026)

InstrumentAmountRating
Cash Credit—Withdrawn
Letter of credit—Withdrawn
Term loan—Withdrawn

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2024-25

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionStableAgency outlook: Stable
CARE rating · May 2025BB

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationNot cooperating since 14 May 2025 (17 months) – investment grade cannot be retained
Credit enhancementNone – standalone rating
WithdrawalCARE · 23 Oct 2025 · Proposed debt rated but not raised
Next action stable or better (model)87%
Information on file44% · missing: Audited financial statements (last 18 months), Debt obligations and repayment schedule, Capex / investment plans, Auditor details, Shareholding pattern

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 87% (Stable or improving) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹170 Cr
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage15.42×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 87% chance the next rating action is stable or better
  • Current rating BB (below investment grade)
  • Interest coverage 15.42×
  • Issuer not cooperating with the rating agency
  • CARE withdrew its ratings on 23 Oct 2025 — usually after the rated bank loans were repaid or moved to another lender

Rated limits by facility

Timeline

23 Oct 2025 CARE withdrawn: BB (Stable) CARE rationale
23 Oct 2025 New borrowing arranged (term loans)
From the report

Further, the Careedge Ratings has withdrawn the rating assigned to the term loan facility with immediate effect as VSL has repaid the facility availed as well as declared that it has not availed the proposed fund-based facility rated by CareEdge Ratings.

CARE rationale
14 May 2025 CARE downgraded: BB (Stable)Rated limits ₹170 cr CARE rationale
23 Feb 2024 CARE revised: BB+ (Stable)Rated limits ₹170 cr CARE rationale
23 Feb 2024 Cash & liquid funds ₹18.68 cr
From the report

VSL’s gross cash accruals remained at Rs.18.68 crore in FY23 with no major long-term debt repayments except lease obligation in FY24.

CARE rationale
23 Feb 2024 Average working-capital utilisation 1%
From the report

Average utilization of its fund-based working capital limits remained low at less than 1% p.a. for last 12 months ending November 2023, however, utilization of non-fund-based limits remained moderate at around 47% p.a. during same period.

CARE rationale
23 Feb 2024 Cash & liquid funds ₹104.25 cr
From the report

Short term investments (including cash and bank balance) continued to remain healthy at Rs.104.25 crore as on March 31, 2023 [PY: Rs.153.31 crore].

CARE rationale
06 Jan 2023 CARE reaffirmed: BBB (Stable)Rated limits ₹170 cr CARE rationale
06 Jan 2023 Cash & liquid funds ₹57 cr
From the report

VSL’s gross cash accruals remained at Rs.57 crore in FY22 with no major long-term debt repayments except low finance lease discharge obligation in FY23.

CARE rationale
06 Jan 2023 Average working-capital utilisation 1%
From the report

Average utilization of its fund-based working capital limits remained low at less than 1% p.a. for last 12 months ending November, 2022, however, utilization of non-fund-based limits remained high at around 88% p.a. during last 12 months ended in September, 2022.

CARE rationale
06 Jan 2023 Cash & liquid funds ₹98 cr
From the report

Current ratio of the company increased from 1.32 times as on March 31, 2021 to 1.71 times as on March 31, 2022 with substantial increase in unencumbered cash and bank balance to Rs.98 crore as on March 31, 2022.

CARE rationale
06 Jan 2023 Cash & liquid funds ₹219 cr
From the report

Short term investments (including margin money as well as unencumbered cash and bank balance) remained at Rs.219 crore as on March 31, 2022 [PY: Rs.81 crore].

CARE rationale
08 Feb 2022 CARE reaffirmed: BBB (Stable)Rated limits ₹170 cr CARE rationale
08 Feb 2022 Average working-capital utilisation 13%
From the report

Average utilization of its fund-based working capital limits remained low at around 13% p.a. for last 12 months ending November, 2021, however, utilization of non-fund-based limits remained high at around 88% p.a. during the same period.

CARE rationale
08 Feb 2022 Cash & liquid funds ₹52.72 cr
From the report

During FY21, the company reported negative cash flow from operations of Rs.52.72 crore owing to increase in inventory coupled with decrease in creditors as on March 31, 2021.

CARE rationale
08 Feb 2022 Cash & liquid funds ₹81.24 cr
From the report

Short term investments including bank FDs in form of margin money as well as unencumbered cash and bank balance remained at Rs.81.24 crore as on March 31, 2021.

CARE rationale
06 Jan 2022 CARE reaffirmed: BBB (Stable)Rated limits ₹240 cr CARE rationale
06 Jan 2022 Average working-capital utilisation 13%
From the report

Average utilization of its fund-based working capital limits remained low at around 13% p.a. for last 12 months ending November, 2021, however, utilization of non-fund-based limits remained high at around 88% p.a. during the same period.

CARE rationale
06 Jan 2022 Cash & liquid funds ₹52.72 cr
From the report

During FY21, the company reported negative cash flow from operations of Rs.52.72 crore owing to increase in inventory coupled with decrease in creditors as on March 31, 2021.

CARE rationale
06 Jan 2022 Cash & liquid funds ₹81.24 cr
From the report

Short term investments including bank FDs in form of margin money as well as unencumbered cash and bank balance remained at Rs.81.24 crore as on March 31, 2021.

CARE rationale
06 Jan 2021 CARE revised: BBB (Stable)Rated limits ₹240 cr CARE rationale
06 Jan 2021 Cash & liquid funds ₹22.57 cr
From the report

Liquidity Indicators Liquidity – Adequate: Liquidity of VSL remained adequate marked by healthy gross cash accruals of Rs.22.57 crore in FY20 with no major long-term debt repayments except finance lease obligation of Rs.0.29 crore in FY21.

CARE rationale
06 Jan 2021 Cash & liquid funds ₹1.23 cr
From the report

As on March 31, 2020, the company had free cash and bank balance of Rs.1.23 crore which increased to Rs.4.50 crore as on September 30, 2020.

CARE rationale
06 Jan 2021 Average working-capital utilisation 17.74%
From the report

Although, average utilisation of fund based limits stood low at 17.74% for last 12 months ending November, 2020, utilisation of non-fund based limits remained full during the same period.

CARE rationale
06 Jan 2021 New borrowing arranged (term loans)
From the report

During FY20 and H1FY21, it availed additional LC limits against 100% FDR margins for import of crude soya oil.

CARE rationale
06 Jan 2021 New borrowing arranged (term loans)
From the report

On account of classification of fixed deposit, against which the company has availed LC limits, as non-current investments, current ratio deteriorated from 1.39 times as on March 31, 2019 to 1.05 times as on March 31, 2020 .

CARE rationale
06 Jan 2021 Cash & liquid funds ₹72.8 cr
From the report

During FY20, the company generated cash flow of Rs.72.80 crore from operating activities as against Rs.73.36 crore in FY19.

CARE rationale
31 Dec 2019 CARE other: — CARE rationale
31 Dec 2019 No long-term debt repayment of no long-term debt (₹14.57 cr)
From the report

Liquidity - Adequate: VSL’s liquidity position remained adequate marked by gross cash accruals of Rs.14.57 crore in FY19 with no long-term debt repayments.

CARE rationale
31 Dec 2019 Cash & liquid funds ₹14.57 cr
From the report

Liquidity - Adequate: VSL’s liquidity position remained adequate marked by gross cash accruals of Rs.14.57 crore in FY19 with no long-term debt repayments.

CARE rationale
31 Dec 2019 Cash & liquid funds ₹16.76 cr
From the report

As on March 31, 2019, the company had free cash and bank balance of Rs.16.76 crore.

CARE rationale
31 Dec 2019 Average working-capital utilisation 45.82%
From the report

Although, average utilisation of fund based limits stood low at 45.82% for last 12 months ending November, 2019, utilisation of non-fund based limits stood high at 91.54% during the same period.

CARE rationale
31 Dec 2019 Cash & liquid funds ₹73.51 cr
From the report

During FY19, the company generated cash flow of Rs.73.51 crore from operating activities as against negative Rs.23.56 crore in FY18.

CARE rationale
04 Apr 2019 CARE other: — CARE rationale
04 Apr 2019 Average working-capital utilisation 46%
From the report

Further, average utilization of fund based working capital borrowing limits of VSL was low at 46% during last 12 months ended January, 2019.

CARE rationale
04 Apr 2019 Cash & liquid funds ₹2.29 cr
From the report

The company does not have long term debt repayment obligation in FY19 except vehicle loan of Rs.0.06 crore against which the company had cash and bank balance of Rs.2.29 crore.

CARE rationale
14 Mar 2018 CARE other: — CARE rationale
14 Mar 2018 Average working-capital utilisation 31%
From the report

Further, average utilization of fund based working capital borrowing limits of VSL was low at 31% during last 12 months ended December, 2017.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeBHAGWATI SADAN SWAMI DAYANAND MARG STATION ROAD,, ALWAR, IN-RJ, 301001
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Vijay Solvex Limited

Competitors10identified
Locations4most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Patanjali Foods Dal & Pulses · Food & Beverages patanjalifoods.com — Mumbai, India
Swiggy E-commerce · Food Delivery swiggy.com 2014 Bangalore, India
Tata Consumer Products Dal & Pulses · Food & Beverages tataconsumer.com 1962 Kolkata, India
Britannia Industries Biscuits & Bakery · Food & Beverages britannia.co.in 1892 Kolkata, India
Heritage Foods Dairy, Ghee & Milk Products · Food & Beverages heritagefoods.in 1992 Hyderabad, India
Hindustan Foods Limited · Manufacturing (Food stuffs) — — Mumbai, Maharashtra, India
Zydus Wellness Packaged Foods & Confectionery · Food & Beverages zyduswellness.com — Ahmedabad, India
Dhampur Bio Organics Limited · Manufacturing (Food stuffs) — — Moradabad, Uttar Pradesh, India
Sapphire Foods India Limited Packaged Foods & Confectionery · Food & Beverages sapphirefoods.in — Panchkula, Haryana, India
Gujarat Tea Processors & Packers Ltd Packaged Foods & Confectionery · Food & Beverages waghbakritea.com — India

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.